Mitel Appoints Pierre-Jean Châlon as SVP of APAC Sales
Dec 05, 2016 13:30 pm UTC| Business
SINGAPORE, Dec. 05, 2016 -- Mitel® (Nasdaq:MITL) (TSX:MNW), a global leader in real-time business, cloud and mobile-first communications, announced today the appointment of Pierre-Jean Châlon to lead its business in the...
Integra LifeSciences Announces Key Executive Appointments
Dec 05, 2016 13:30 pm UTC| Business
PLAINSBORO, N.J., Dec. 05, 2016 -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced key executive appointments effective December 1, 2016. Robert T. Davis, Jr., corporate vice president and...
PositiveID Successfully Tests First Bluetooth Version of its Caregiver Thermometer
Dec 05, 2016 13:30 pm UTC| Business
DELRAY BEACH, Fla., Dec. 05, 2016 -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today it has conducted successful testing of...
MYnd Analytics Inc. to Present at the 9th Annual LD Micro Main Event
Dec 05, 2016 13:30 pm UTC| Business
NEW YORK, Dec. 05, 2016 -- MYnd Analytics, Inc. (OTCQB:MYAN), a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide...
Dec 05, 2016 13:30 pm UTC| Business
VANCOUVER, British Columbia, Dec. 05, 2016 -- Novelion Therapeutics Inc.(NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases(the...
OncoMed Announces Departure of Chief Medical Officer
Dec 05, 2016 13:30 pm UTC| Business
REDWOOD CITY, Calif. , Dec. 05, 2016 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology therapeutics, today...
SteadyMed Provides Update on IPR Hearing
Dec 05, 2016 13:30 pm UTC| Business
SAN RAMON, Calif., Dec. 05, 2016 -- SteadyMed Therapeutics Ltd. (NASDAQ:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet...